Abbott Laboratories’ ABT growth in the third quarter of 2024 can be attributed to strong sales recovery within the Nutrition ...

Within Abbott’s Established Pharmaceuticals Division (EPD) business ... as well as its array of new product launches, are expected to help the stock continue with its uptrend in the coming ...

The overall business is particularly expanding on strong global demand for the company’s adult nutrition products ... this region. EPD Business Set for Sustainable Growth: Abbott’s EPD ...